Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
5 Results Found
FDA alerts of risk with Calyxo aspiration systems
The Food and Drug Administration March 20 issued an alert on a potentially high-risk issue with Calyxo CVAC Aspiration Systems.
AHA podcast: A Tiered System of Safety — Committing to Zero Harm with WellSpan Health
In this conversation, Carlos Roberts, M.D., urogynecologist, vice president and chief medical officer of the Women and Children service line at WellSpan Health, discusses the organization's commitm
AHA podcast: To Mitigate and Prevent — CommonSpirit Health's Transparent Culture and Error Reporting Toolkit
In this “Safety Speaks” conversation, CommonSpirit Health's Beth Miller, system director, patient safety-performance improvement, and Austin Peterson, system director, patient harm prevention, discuss how safety transparency benefits both patients and providers, and how a CommonSpirit Health toolkit can help organizations lead the way in error reporting and patient safety.
FDA withdraws accelerated approval of myeloma drug
The Food and Drug Administration Feb. 23 withdrew approval of Pepaxto (melphalan flufenamide), a drug once used with dexamethasone to treat certain U.S. patients with multiple myeloma, because a post-approval trial did not show it safe or effective.
AHA comments on proposed AHRQ initiative to advance patient safety
AHA submitted comments on how the Agency for Healthcare Research and Quality can best support the field in advancing patient safety through an action alliance, which the agency is launching in partnership with health care systems and patient safety advocates